… Anakinra, an anti-IL-1, is another therapeutic option for treating patients suffering of severe
COVID-19. It is a recombinant and slightly modified version of the human interleukin 1 …

… Therapeutic options for COVID-19 are meek; a … , therapeutic options include vaccine
development, convalescent plasma therapy, corticosteroids, and CRISPR/Cas-mediated therapy. …

… There is a compelling need for highly effective and rapidly implementable antiviral compounds
and therapies, especially because early therapeutic options have shown only minimal …

… Among these, CR3022 was also found to bind with the SARS-CoV-2 RBD (88), and it
might be a possible therapeutic option for the treatment of COVID-19 disease. Recently, …

… COVID-19 patients in China, and is worthy of further studies. In this review, we aim to highlight
the available therapeutic options for COVID-19 … disease or at the early stage of COVID-19. …

… Potent therapeutic options were reviewed and future challenges to accelerate the
development of novel therapeutic agents to treat and prevent COVID‑19 were acknowledged. …

… on different pharmacological and non-pharmacological therapeutic options for COVID-19,
and assess the methodological and reporting quality of the existing systematic reviews. …

… In addition to therapeutic properties of these anti-COVID-19 compounds, some adverse …
therapy and treatment of COVID-19, but also nanomedicine, immunotherapy, and cell therapy …

… all examples of therapeutic agents, whose efficacy against COVID-19 was later … therapeutic
options to control the disease including PAXLOVID™ (PF-07321332). Although COVID-19 …

… of therapy, reversal of risk factors, and adoption of a multipronged treatment strategy. It also
details the various therapeutic options (in … on the link between COVID-19 and the various risk …